Gynecological Cancers: Genetic and Epigenetic Targets and Drug Development (Current Clinical Oncology) 1st ed. 2016 Edition
[amazon_link asins=’3319329057′ template=’ProductAd’ store=’aishabano-20′ marketplace=’US’ link_id=’fe6cf3fc-374e-11e8-a4b9-cd11fc42a6ca’]
Facilitating the collaboration between the basic, translational, and clinical sciences, this book provides an overview of the genetic and epigenetic mechanisms underlying the formation and progression of gynecological cancers. Gynecological Cancers: Genetic and Epigenetic Targets and Drug Development gathers all of the molecular and cellular aspects of gynecological cancer together within one volume, providing detailed and up-to-date information on the etiology, diagnosis, and treatment of gynecological cancers.
Gynecological Cancers: Genetic and Epigenetic Targets and Drug Development also discusses the racial and ethnic disparities in the treatment of gynecological cancers through cost effective modalities like single visit screening and diagnosis, well women clinics, and mobile clinics. Written and edited by leaders in the field, this volume within the Current Clinical Oncology series is an indispensable resource for today’s practicing oncologist.